By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a




Company News
TapImmune Inc. (TPIV) To Present At 17th Annual Rodman & Renshaw Healthcare Conference 9/2/2015 9:04:19 AM
TapImmune Inc. (TPIV) Completes Transfer of IND From The Mayo Clinic 8/18/2015 6:48:46 AM
TapImmune Inc. (TPIV) Appoints John N. Bonfiglio, Ph.D., To Its Board Of Directors 7/30/2015 11:57:25 AM
TapImmune Inc. (TPIV) Announces Finalization Of License Agreement With Mayo Clinic To Commercialize A Folate Receptor Alpha Vaccine For Multiple Cancer Indications 7/27/2015 11:09:32 AM
TapImmune Inc. (TPIV) Reports Robust Immune Responses Generated In 19 Of 20 Evaluable HER2/Neu Breast Cancer Patients 6/23/2015 6:43:48 AM
TapImmune Inc. (TPIV) Announces Immediate Infusion of $2.5 Million Dollars From Largest Institutional Investor 6/19/2015 6:46:29 AM
TapImmune Inc. (TPIV) Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 6/3/2015 9:09:19 AM
TapImmune Inc. (TPIV) To Present Clinical & Scientific Update At The 2015 Marcum Microcap Conference 5/20/2015 7:43:43 AM
TapImmune Inc. (TPIV) Release: Phase I Study In Ovarian & Breast Cancer Published In Abstracts Of 2015 ASCO Annual Meeting 5/15/2015 6:42:36 AM
TapImmune Inc. (TPIV) Release: Despite Unimpressive Company Guidance Shares Soar - BrokerBank Securities 5/13/2015 11:01:38 AM